Reduced risk of Efavirenz Discontinuation in Naive Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen

摘要

ObjectivesDespite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in naive patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR.